Clinical Trials on Plasma Volume in Ireland
Total 108 results
-
University of Dublin, Trinity CollegeCompletedLow Tidal Volume VentilationIreland
-
Royal College of Surgeons, IrelandpatientMpower Ltd.Completed
-
CardioKine Inc.Biogen; Cardiokine Biopharma, LLCCompletedHyponatremia With Excess Extracellular Fluid Volume | Hyponatremia With Normal Extracellular Fluid VolumeUnited States
-
Royal College of Surgeons, IrelandpatientMpower Ltd.; Enterprise Ireland; Beaumont Hospital; Design to Value LtdCompletedEnd Stage Renal Disease | Dialysis; Complications | Volume OverloadIreland
-
University of Dublin, Trinity CollegeNational Health Service, United KingdomCompletedMeaning, Value and Purpose of AACIreland
-
Cancer Trials IrelandCompleted
-
Rigshospitalet, DenmarkCompleted
-
The Miriam HospitalRecruitingSepsis | Septic Shock | Sepsis, Severe | Volume OverloadUnited States
-
PepsiCo Global R&DCompletedMicrobiome | Plasma Cholesterol | PrebioticIreland
-
National University of Ireland, Galway, IrelandJanssen Pharmaceuticals; Cancer Trials IrelandUnknownMultiple MyelomaIreland
-
West of Scotland Lymphoma GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
University College CorkCancer Research@UCCRecruiting
-
Cancer Trials IrelandBristol-Myers Squibb; Janssen PharmaceuticalsActive, not recruiting
-
CardioKine Inc.Biogen; Cardiokine Biopharma, LLCCompletedHyponatremia With Normal Extracellular Fluid VolumeUnited States, Canada, Germany, India, Poland, Belgium
-
Cancer Trials IrelandSanofi; Dana-Farber Cancer InstituteRecruitingMultiple MyelomaDenmark, Ireland
-
AO Innovation Translation CenterAO Foundation, AO SpineRecruitingSpinal Column TumorUnited States, Canada, Italy, Australia, China, Germany, Hungary, Japan, United Kingdom
-
University of IcelandMemorial Sloan Kettering Cancer Center; Landspitali University Hospital; deCODE... and other collaboratorsActive, not recruitingMonoclonal Gammopathy of Undetermined SignificanceIceland
-
Landspitali University HospitalMemorial Sloan Kettering Cancer Center; Celgene; Amgen; University of IcelandEnrolling by invitationMultiple Myeloma | Smoldering Multiple MyelomaIceland
-
Cancer Trials IrelandCompleted
-
Janssen Research & Development, LLCNo longer availableRelapsed or Refractory Multiple MyelomaBelgium, Iceland, Portugal, Slovenia
-
Leeds Cancer Centre at St. James's University HospitalUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Celgene CorporationCompletedMultiple MyelomaIreland, Spain, Australia, Austria, United Kingdom
-
GlycoMimetics IncorporatedCompletedMultiple MyelomaIreland, Denmark, United Kingdom, Germany
-
University of GlasgowCompletedRenal Failure | Multiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
John L. ReaganThe Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode IslandActive, not recruiting
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Urinary Complications | Breast Adenocarcinoma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | Metastatic Malignant Neoplasm to the Bone | Musculoskeletal ComplicationUnited States, Puerto Rico
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Spectrum Pharmaceuticals, IncCompletedLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Lymphoma, B-Cell, Marginal Zone | Waldenstrom Macroglobulinemia | Lymphoma, Small-CellUnited States
-
NovartisCompletedMultiple MyelomaCanada, United States, Australia, Taiwan, Ireland
-
PfizerBristol-Myers SquibbRecruiting
-
OncotherapeuticsAmgenTerminatedMultiple MyelomaUnited States
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.CompletedMultiple MyelomaNorway, Sweden, Denmark, Finland, Iceland
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Aronex PharmaceuticalsCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Infection | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States, Puerto Rico
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
CelgeneCompletedMultiple MyelomaNetherlands, Spain, Belgium, Austria, Switzerland, Italy, Germany, France, Ireland, United Kingdom, Denmark, Finland, Portugal, Turkey, Poland, Estonia, Greece, Norway, Slovakia, Sweden
-
Tarix PharmaceuticalsConstant Therapeutics LLCTerminatedLymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin DiseaseUnited States
-
PfizerAvailableMultiple MyelomaUnited States, Canada
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
PfizerRecruitingMultiple MyelomaUnited States, Canada
-
PfizerCompletedMultiple MyelomaCanada, United States
-
CelgeneCompletedMultiple MyelomaSpain, United Kingdom, Switzerland, Australia, Israel, Italy, Poland, France, Belgium, Ireland, Austria, Germany, Ukraine, Greece, Sweden